Core Viewpoint - The stock of Pioneer Pharma Biotechnology (00399) experienced a decline of 6.35% on August 1, trading at HKD 0.59 per share with a transaction volume of HKD 1.093 million [1]. Group 1: Company Overview - Pioneer Pharma Biotechnology focuses on the research and development of pharmaceutical products and the trade of beauty instruments and products, particularly oral insulin products [1]. - The company is actively seeking pharmaceutical products with commercial development potential to expand its research and development scope [1]. - Pioneer Pharma is listed on the main board of the Hong Kong Stock Exchange under stock code 399 [1]. Group 2: Financial Performance - As of the 2024 annual report, Pioneer Pharma Biotechnology reported total revenue of HKD 1.9296 million and a net loss of HKD 319 million [2].
领航医药生物科技(00399)下跌6.35%，报0.59元/股